ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $72,000 | +71.4% | 20,000 | -24.5% | 0.04% | +44.4% |
| Q4 2018 | $42,000 | -73.1% | 26,500 | -37.6% | 0.03% | -66.2% |
| Q3 2018 | $156,000 | +69.6% | 42,500 | +30.8% | 0.08% | +63.3% |
| Q2 2018 | $92,000 | -24.0% | 32,500 | -0.0% | 0.05% | -25.8% |
| Q1 2018 | $121,000 | -13.6% | 32,502 | -33.0% | 0.07% | -14.3% |
| Q4 2017 | $140,000 | +6.1% | 48,504 | +64.4% | 0.08% | -1.3% |
| Q3 2017 | $132,000 | -16.5% | 29,500 | -14.5% | 0.08% | -21.2% |
| Q2 2017 | $158,000 | +9.0% | 34,500 | 0.0% | 0.10% | +8.8% |
| Q1 2017 | $145,000 | +2.1% | 34,500 | 0.0% | 0.09% | +2.2% |
| Q4 2016 | $142,000 | -18.4% | 34,500 | +60.5% | 0.09% | -19.8% |
| Q3 2016 | $174,000 | -26.9% | 21,500 | -29.5% | 0.11% | -27.9% |
| Q2 2016 | $238,000 | +43.4% | 30,500 | +41.9% | 0.15% | +38.7% |
| Q1 2016 | $166,000 | +33.9% | 21,500 | +87.0% | 0.11% | +38.8% |
| Q4 2015 | $124,000 | -70.4% | 11,500 | -81.1% | 0.08% | -72.7% |
| Q3 2015 | $419,000 | -47.9% | 60,700 | -33.1% | 0.29% | -39.8% |
| Q2 2015 | $804,000 | +48.1% | 90,700 | +64.6% | 0.49% | +46.7% |
| Q1 2015 | $543,000 | +35.4% | 55,100 | +68.5% | 0.33% | +35.5% |
| Q4 2014 | $401,000 | +100.5% | 32,700 | +63.5% | 0.24% | +109.4% |
| Q3 2014 | $200,000 | +102.0% | 20,000 | -33.3% | 0.12% | +88.7% |
| Q1 2014 | $99,000 | – | 30,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |